Michele Valmasoni MD PhD FACS

149 posts

Michele Valmasoni MD PhD FACS banner
Michele Valmasoni MD PhD FACS

Michele Valmasoni MD PhD FACS

@mvalma

Director @UpperGIPadova, Padova University Hospital - Ass Professor of Surgery @UniPadova. Husband, Shih Tzu lover, photographer, Apple fanboy.

Italy/Padova Katılım Temmuz 2009
159 Takip Edilen117 Takipçiler
Michele Valmasoni MD PhD FACS retweetledi
JAMA Surgery
JAMA Surgery@JAMASurgery·
Standard esophagectomy after neoadjuvant chemoradiation may provide greater long-term survival and quality-of-life benefits than active surveillance for most patients with esophageal cancer. ja.ma/4sPlBNb
JAMA Surgery tweet media
English
2
11
43
8.7K
Michele Valmasoni MD PhD FACS retweetledi
ASCO
ASCO@ASCO·
Delving into the“Organ Preservation for Gastroesophageal Junction & Gastric Adenocarcinoma: Ready for Primetime?” w co-chairs Drs. Daniel Tandel Chang & Ugwuji Maduekwe @ #GI26. Case-based discussions w/ opposing views. 🔥 #esocsm brnw.ch/21wYVT0 @Daniela_Molena @IkomaMD
ASCO tweet mediaASCO tweet mediaASCO tweet mediaASCO tweet media
English
0
2
4
1.3K
Michele Valmasoni MD PhD FACS retweetledi
JAMA Surgery
JAMA Surgery@JAMASurgery·
Patients who received robot-assisted surgery vs conventional laparoscopic surgery had a higher incidence of postoperative pulmonary complications and received longer and more intense mechanical ventilation. ja.ma/3JZ0p62
JAMA Surgery tweet media
English
0
19
57
8.9K
Michele Valmasoni MD PhD FACS retweetledi
JAMA Surgery
JAMA Surgery@JAMASurgery·
Robotic hiatal hernia repair offered no short-term morbidity or mortality advantage over laparoscopic hiatal hernia repair but incurred longer operative times and a higher pulmonary embolism risk in older adults. ja.ma/4qEFHc8
JAMA Surgery tweet media
English
1
11
41
4.8K
Michele Valmasoni MD PhD FACS retweetledi
Università di Padova
Università di Padova@UniPadova·
🏥 Inaugurato il Nuovo Ospedale Pediatrico del Veneto “Salus Pueri”. Una struttura moderna, ispirata alla natura, che unisce cura, ricerca e formazione unipd.link/inaugurazione-…
Università di Padova tweet mediaUniversità di Padova tweet mediaUniversità di Padova tweet mediaUniversità di Padova tweet media
Italiano
1
3
5
1.2K
Michele Valmasoni MD PhD FACS retweetledi
Sheraz Markar
Sheraz Markar@MarkarSheraz·
SANO trial: innovations, risks, and unanswered questions - felt very strongly along with several UGI colleagues we must highlight the important limitations of the SANO trial and thus counsel our patients appropriately regarding these results! ⁦ thelancet.com/journals/lanon…
English
0
9
17
1.9K
Michele Valmasoni MD PhD FACS retweetledi
Annals of Surgery
Annals of Surgery@AnnalsofSurgery·
Real-world application of endoscopic resection for early-stage esophageal cancer: do we need to rethink the guidelines? journals.lww.com/annalsofsurger…
English
0
5
14
2.7K
Michele Valmasoni MD PhD FACS retweetledi
NEJM
NEJM@NEJM·
ESOPEC, a large randomized trial involving patients with resectable esophageal cancer, showed that perioperative chemotherapy improved overall survival as compared with preoperative chemoradiotherapy. Full trial results: nej.md/4apWlo5 Editorial: Multimodal Treatment in Locally Advanced Esophageal Adenocarcinoma — Two Interventions Better Than Three? nej.md/40rpHhl
NEJM tweet media
English
2
56
131
26.8K
Michele Valmasoni MD PhD FACS retweetledi
Tim Cook
Tim Cook@tim_cook·
Steve showed us that the future isn’t something you wait for—it’s something you build. His memory lives on in the hearts of innovators and dreamers everywhere—at Apple and beyond.
Tim Cook tweet media
English
1.9K
6.4K
48.8K
2.2M
Michele Valmasoni MD PhD FACS retweetledi
Artwithpeter🌈
Artwithpeter🌈@KEN_K_·
I am pleased to inform you that the primary result of JCOG1109 was published in the Lancet today. The neoadjuvant triplet chemotherapy would be the standard care for the locally advanced ESCC. Many thanks to everyone involved. thelancet.com/action/showPdf…
English
3
15
50
6.2K